Application 205234

Type
ANDA
Sponsor
ALEMBIC PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANTABLET;ORALEQ 5MG BASE;40MGNoNo
002TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANTABLET;ORALEQ 10MG BASE;40MGNoNo
003TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANTABLET;ORALEQ 5MG BASE;80MGNoNo
004TELMISARTAN AND AMLODIPINEAMLODIPINE BESYLATE; TELMISARTANTABLET;ORALEQ 10MG BASE;80MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
46708-184Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-184Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-185Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-185Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-186Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-186Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-187Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent
46708-187Telmisartan and AmlodipineTelmisartan and AmlodipineAlembic Pharmaceuticals LimitedANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
46029ORIG2016-12-06